US RSV shot limits clash with evidence of 81% efficacy
New US policy restricts RSV vaccines to high-risk infants despite studies showing shots cut hospitalisations by 81%. Experts warn the move could reverse progress against the dangerous virus.
Category : Search result: monoclonal antibodies
Llama antibodies show promise in Alzheimer's breakthrough
Scientists discover that tiny antibodies from llamas could neutralise toxic proteins linked to Alzheimer's disease, offering new hope for treatment development.
Llama antibodies may transform schizophrenia treatment
Groundbreaking research reveals that antibodies from llamas could revolutionise schizophrenia treatment, offering new hope for patients.
Page 1 of 1